These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16146509)

  • 1. Platelet counts in pools of platelet-rich plasma-derived platelet concentrates.
    Sweeney JD; Holme S
    Vox Sang; 2005 Oct; 89(3):168; author reply 169. PubMed ID: 16146509
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation and standardisation of platelet rich plasma and platelet concentrates in a developing blood bank.
    Nanu A; Taneja N; Sood SK
    Indian J Med Res; 1980 Apr; 71():661-7. PubMed ID: 7390605
    [No Abstract]   [Full Text] [Related]  

  • 3. [The preparation of platelet-rich plasma for platelet counts and tests of platelet function (author's transl)].
    Schulz V; Kochsiek K; Köstering H; Walther Ch
    Z Klin Chem Klin Biochem; 1971 Jul; 9(4):324-8. PubMed ID: 4951027
    [No Abstract]   [Full Text] [Related]  

  • 4. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
    Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
    Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fully automated processing of buffy coat-derived pooled concentrates.
    Larrea L; Ortiz de Salazar MI; Roig R; Soler MA
    Transfusion; 2005 Apr; 45(4):642; author reply 642-3. PubMed ID: 15819689
    [No Abstract]   [Full Text] [Related]  

  • 6. Do diluents interfere with the determination of platelet count in platelet concentrates?
    Ringwald J; Friedhoff H; Weiss D; Eckstein R; Antoon M
    Transfusion; 2010 Jun; 50(6):1403-4. PubMed ID: 20598105
    [No Abstract]   [Full Text] [Related]  

  • 7. [Automation in the preparation of labile blood products].
    Tardivel R; Bois S; Vignoli C; Naegelen C; Isola H
    Transfus Clin Biol; 2009 May; 16(2):175-8. PubMed ID: 19446485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Impact-R for monitoring the platelet storage lesion.
    Albanyan AM; Murphy MF; Harrison P
    Platelets; 2009 Feb; 20(1):1-6. PubMed ID: 19172514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of platelet activation and apoptosis in platelet concentrates collected by apheresis.
    Procházková R; Andrýs C; Hubácková L; Krejsek J
    Transfus Apher Sci; 2007 Oct; 37(2):115-23. PubMed ID: 17945536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers.
    Arnold DM; Heddle NM; Kulczycky M; Carruthers J; Sigouin C; Blajchman MA
    Transfusion; 2006 Feb; 46(2):257-64. PubMed ID: 16441604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
    Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
    Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some observations on the preparation of platelet-rich plasma.
    Woods BP; Dennehy A; Clarke N
    Thromb Haemost; 1976 Nov; 36(2):302-10. PubMed ID: 1036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).
    Dohan Ehrenfest DM; Rasmusson L; Albrektsson T
    Trends Biotechnol; 2009 Mar; 27(3):158-67. PubMed ID: 19187989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical comparison of platelet preparation methods.
    Vassallo RR; Murphy S
    Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies.
    Dohan Ehrenfest DM; de Peppo GM; Doglioli P; Sammartino G
    Growth Factors; 2009 Feb; 27(1):63-9. PubMed ID: 19089687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two platelet count estimation methodologies for peripheral blood smears.
    Malok M; Titchener EH; Bridgers C; Lee BY; Bamberg R
    Clin Lab Sci; 2007; 20(3):154-60. PubMed ID: 17691671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stored platelet concentrates produced by the platelet-rich plasma method are more resistant to apoptosis but more sensitive to activation than are platelets prepared by the buffy-coat and apheresis methods.
    Leytin V; Allen DJ; Mutlu A; Mykhaylov S; Lyubimov E; Freedman J
    Transfusion; 2009 Jul; 49(7):1493-4. PubMed ID: 19602211
    [No Abstract]   [Full Text] [Related]  

  • 18. Storage of platelet-rich plasma-derived platelet concentrate pools in plasma and additive solution.
    Sweeney J; Kouttab N; Holme S; Kurtis J; Cheves T; Nelson E
    Transfusion; 2006 May; 46(5):835-40. PubMed ID: 16686852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of platelet concentrates during storage: Platelet counts and markers of platelet destruction.
    Apelseth TO; Hervig T
    Transfus Apher Sci; 2007 Dec; 37(3):261-8. PubMed ID: 18036986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cord blood platelet characteristics and hematopoietic progenitor cells.
    Eskola M; Rekunen S; Aroviita P; Möttönen S; Hiilesmaa V; Sainio S; Kekomäki R
    Transfusion; 2008 May; 48(5):884-92. PubMed ID: 18298598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.